Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia. [electronic resource]
Producer: 20140520Description: 239-48 p. digitalISSN:- 1743-7563
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Australia
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Cost-Benefit Analysis
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Neoplasm Metastasis
- Organoplatinum Compounds -- administration & dosage
- Oxaloacetates
- Randomized Controlled Trials as Topic -- economics
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.